Overview

Role of Oral Zinc in Reducing Neonatal Indirect Hyperbilirubinemia

Status:
COMPLETED
Trial end date:
2020-01-01
Target enrollment:
Participant gender:
Summary
This study aimed to determine the role of oral zinc in reducing the neonatal indirect hyperbilirubinemia if used concomitant with the standard phototherapy
Phase:
PHASE3
Details
Lead Sponsor:
National Liver Institute, Egypt
Treatments:
Zinc Sulfate